References
- Birge, O., et al., 2021. Risk factors that increase recurrence in borderline ovarian cancers. American Journal of Translational Research, 13 (7), 8438–8449.
- Casarin, J., et al., 2020. Surgical treatment of large adnexal masses: a retrospective analysis of 330 consecutive cases. Minimally Invasive Therapy & Allied Technologies, 29 (6), 366–374.
- Carter, J., et al., 2012. Contemporary quality of life issues affecting gynecologic cancer survivors. Hematology/Oncology Clinics of North America, 26 (1), 169–194.
- Classification and staging of malignant tumours in the female pelvis, 1971. Acta Obstetricia et Gynecologica Scandinavica, 50 (1), 1–7.
- Daraï, E., et al., 2013. Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Human Reproduction Update, 19 (2), 151–166.
- Dessole, M., et al., 2018. Quality of life in women after pelvic exenteration for gynecological malignancies: a multicentric study. International Journal of Gynecological Cancer, 28 (2), 267–273.
- Du Bois, A., et al., 2013. Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group. European Journal of Cancer, 49 (8), 1905–1914.
- Fagotti, A., et al., 2016. Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): final analysis of peri-operative outcome. European Journal of Cancer, 59, 22–33.
- Fang, C., et al., 2018. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors. BMC Cancer, 18 (1), 1147.
- Fischerova, D., et al., 2012. Diagnosis, treatment, and follow-up of borderline ovarian tumors. The Oncologist, 17 (12), 1515–1533.
- Gco.iarc.fr. 2022. Population fact sheets [online]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/422-lebanon-fact-sheets.pdf [Accessed 20 September 2022].
- Gullo, G., et al., 2021. Fertility-sparing approach in women affected by stage I and low-grade endometrial carcinoma: an updated overview. International Journal of Molecular Sciences, 22 (21), 11825.
- Hauptmann, S., et al., 2017. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Archiv, 470 (2), 125–142.
- Ifthikar, M.A., et al., 2020. Retrospective analysis of factors affecting recurrence in borderline ovarian tumors. South Asian Journal of Cancer, 09 (03), 168–173.
- Kane, A., et al., 2009. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants. The Oncologist, 14 (6), 591–600.
- Laganà, A.S., et al., 2017. Psychological impact of fertility preservation techniques in women with gynaecological cancer. Ecancermedicalscience, 11, ed62.
- Momenimovahed, Z., et al., 2019. Ovarian cancer in the world: epidemiology and risk factors. International Journal of Women’s Health, 11, 287–299.
- Morice, P., et al., 2012. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. The Lancet. Oncology, 13 (3), e103–e115.
- Raimondo, D., et al., 2022. The impact of hysterectomy on oncological outcomes in patients with borderline ovarian tumors: a systematic review and meta-analysis. Gynecologic Oncology, 165 (1), 184–191.
- Schneider, A., et al., 2012. Clinical recommendation radical trachelectomy for fertility preservation in patients with early-stage cervical cancer. International Journal of Gynecological Cancer, 22 (4), 659–666.
- Shamseddine, A., et al., 2014. Cancer trends in Lebanon: a review of incidence rates for the period of 2003-2008 and projections until 2018. Population Health Metrics, 12 (1), 4.
- Sherman, M.E., et al., 2004. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Cancer, 100 (5), 1045–1052.
- Siegel, R.L., et al., 2021. Cancer statistics. CA: A Cancer Journal for Clinicians, 71 (1), 7–33. Erratum in: CA Cancer J Clin. 2021 Jul;71(4):359.
- Song, T., et al., 2018. Elevated preoperative CA125 or CA19-9 in borderline ovarian tumors: could it be suggestive of advanced stage or a poor prognosis? Gynecologic and Obstetric Investigation, 83 (1), 45–51.
- Trillsch, F., et al., 2010. Clinical management of borderline ovarian tumors. Expert Review of Anticancer Therapy, 10 (7), 1115–1124.
- Trillsch, F., et al., 2014. Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study. Annals of Oncology, 25 (7), 1320–1327.
- Uzan, C., et al., 2014. Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary. Annals of Oncology, 25 (1), 166–171.
- Wong, H.F., et al., 2007. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004. International Journal of Gynecological Cancer, 17 (2), 342–349.
- Zanetta, G., et al., 2001. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. Journal of Clinical Oncology, 19 (10), 2658–2664.